• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亚洲国家 1990-2019 年精神障碍负担:2019 年全球疾病负担研究分析。

The burden of mental disorders in Asian countries, 1990-2019: an analysis for the global burden of disease study 2019.

机构信息

Department of Gastroenterology, the Affiliated Hospital of Southwest Medical University, Luzhou, China.

Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province, Luzhou, China.

出版信息

Transl Psychiatry. 2024 Mar 28;14(1):167. doi: 10.1038/s41398-024-02864-5.

DOI:10.1038/s41398-024-02864-5
PMID:38548717
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10978857/
Abstract

Mental disorders are the leading contributors to the globally nonfatal burden of disease. This study was aimed to estimate the burden of mental disorders in Asian countries. Based on GBD 2019, the prevalence and disability-adjusted life of years (DALYs) rates with 95% uncertainty intervals (UI) were estimated in Asian countries. Predictions for the future burden of 8 selected countries, ranks of the burden of mental disorders and correlations with Sociodemographic Index (SDI) were also estimated. During the past 3 decades, while the number of DALYs of mental disorders increased from 43.9 million (95% UI: 32.5-57.2) to 69.0 million (95% UI: 51.0-89.7), the age-standardized rates of DALYs of mental disorders remained largely consistent from 1452.2 (95% UI: 1080.16-1888.53) per 100,000 population in 1990 to 1434.82 (95% UI: 1065.02-1867.27) per 100,000 population in 2019, ranked as the eighth most significant disease burden in Asia in 2019. Depressive disorders (37.2%) were the leading contributors to the age-standardized DALY rates of mental disorders in Asia, followed by anxiety disorders (21.5%). The age-standardized DALY rates in females were higher than their male counterparts, both peaked at 30-34 years. The age-standardized DALY rates were predicted to remain stable, with the number of DALYs presented an upward trend in the future. There was no significant correlation between the burden of mental disorders and SDI. All mental disorders ranked higher in 2019, compared in 1990. To reduce this burden, urgent measures for prevention, treatment, and rehabilitation for mental disorders need to be taken by Asian governments.

摘要

精神障碍是全球非致命疾病负担的主要原因。本研究旨在估计亚洲国家精神障碍的负担。基于 GBD 2019,估计了亚洲国家精神障碍的患病率和残疾调整生命年(DALYs)率及其 95%置信区间(UI)。还预测了 8 个选定国家的未来负担、精神障碍负担的排名以及与社会人口指数(SDI)的相关性。在过去的 30 年中,尽管精神障碍的 DALYs 数量从 4390 万(95%UI:3250-5720)增加到 6900 万(95%UI:5100-8970),但精神障碍的年龄标准化 DALYs 率在很大程度上保持不变,从 1990 年的每 10 万人 1452.2(95%UI:1080.16-1888.53)到 2019 年的每 10 万人 1434.82(95%UI:1065.02-1867.27),在 2019 年被列为亚洲第八大疾病负担。在亚洲,抑郁障碍(37.2%)是导致精神障碍年龄标准化 DALY 率的主要原因,其次是焦虑障碍(21.5%)。女性的年龄标准化 DALY 率高于男性,两者都在 30-34 岁达到峰值。预计年龄标准化 DALY 率将保持稳定,未来 DALYs 数量呈上升趋势。精神障碍负担与 SDI 之间没有显著相关性。与 1990 年相比,所有精神障碍在 2019 年的排名都更高。为了减轻这一负担,亚洲各国政府需要采取紧急措施,预防、治疗和康复精神障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/7b6f3bde6836/41398_2024_2864_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/5a42065ddb6d/41398_2024_2864_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/28f5d5a52e91/41398_2024_2864_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/33375b4dde67/41398_2024_2864_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/7f64f3c74623/41398_2024_2864_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/3ad9f6125068/41398_2024_2864_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/0eb6cb5287e9/41398_2024_2864_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/187a9d649a5f/41398_2024_2864_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/33b0f9bdf3cd/41398_2024_2864_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/fb47789d2e30/41398_2024_2864_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/75bc8d57e208/41398_2024_2864_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/7b6f3bde6836/41398_2024_2864_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/5a42065ddb6d/41398_2024_2864_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/28f5d5a52e91/41398_2024_2864_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/33375b4dde67/41398_2024_2864_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/7f64f3c74623/41398_2024_2864_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/3ad9f6125068/41398_2024_2864_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/0eb6cb5287e9/41398_2024_2864_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/187a9d649a5f/41398_2024_2864_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/33b0f9bdf3cd/41398_2024_2864_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/fb47789d2e30/41398_2024_2864_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/75bc8d57e208/41398_2024_2864_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b068/10978857/7b6f3bde6836/41398_2024_2864_Fig11_HTML.jpg

相似文献

1
The burden of mental disorders in Asian countries, 1990-2019: an analysis for the global burden of disease study 2019.亚洲国家 1990-2019 年精神障碍负担:2019 年全球疾病负担研究分析。
Transl Psychiatry. 2024 Mar 28;14(1):167. doi: 10.1038/s41398-024-02864-5.
2
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家 204 个地区 1990-2019 年 12 种精神障碍疾病的负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10.
3
Trends in the prevalence and disability-adjusted life years of eating disorders from 1990 to 2017: results from the Global Burden of Disease Study 2017.1990 年至 2017 年饮食失调症的流行趋势和残疾调整生命年数:2017 年全球疾病负担研究结果。
Epidemiol Psychiatr Sci. 2020 Dec 7;29:e191. doi: 10.1017/S2045796020001055.
4
Burden of Common Neurologic Diseases in Asian Countries, 1990-2019: An Analysis for the Global Burden of Disease Study 2019.亚洲国家常见神经疾病负担,1990-2019 年:2019 年全球疾病负担研究分析。
Neurology. 2023 May 23;100(21):e2141-e2154. doi: 10.1212/WNL.0000000000207218. Epub 2023 Apr 4.
5
Prevalence, Deaths, and Disability-Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990-2017.1990 - 2017年195个国家和地区肌肉骨骼疾病的患病率、死亡人数及伤残调整生命年
Arthritis Rheumatol. 2021 Apr;73(4):702-714. doi: 10.1002/art.41571. Epub 2021 Feb 22.
6
The burden of depressive disorders in South Asia, 1990-2016: findings from the global burden of disease study.1990-2016 年南亚地区抑郁障碍负担:来自全球疾病负担研究的发现。
BMC Psychiatry. 2018 Oct 16;18(1):333. doi: 10.1186/s12888-018-1918-1.
7
Burden of esophageal cancer between 2010 and 2019 in Asian countries by geographical region and sociodemographic index: A comparison with global data.2010 年至 2019 年亚洲国家按地理位置和社会人口指数划分的食管癌负担:与全球数据的比较。
Thorac Cancer. 2023 Aug;14(24):2361-2407. doi: 10.1111/1759-7714.15026. Epub 2023 Jul 17.
8
Global, regional, national burden and gender disparity of cataract: findings from the global burden of disease study 2019.白内障的全球、区域、国家负担及性别差异:全球疾病负担研究2019的结果
BMC Public Health. 2022 Nov 12;22(1):2068. doi: 10.1186/s12889-022-14491-0.
9
Global, regional and national burden of rheumatoid arthritis 1990-2017: a systematic analysis of the Global Burden of Disease study 2017.全球、地区和国家类风湿关节炎负担 1990-2017 年:2017 年全球疾病负担研究的系统分析。
Ann Rheum Dis. 2019 Nov;78(11):1463-1471. doi: 10.1136/annrheumdis-2019-215920. Epub 2019 Sep 11.
10
Global, regional, and national prevalence, disability adjusted life years, and time trends for refraction disorders, 1990-2019: findings from the global burden of disease study 2019.全球、地区和国家的屈光不正患病率、残疾调整生命年以及时间趋势,1990-2019 年:2019 年全球疾病负担研究的结果。
BMC Public Health. 2021 Sep 6;21(1):1619. doi: 10.1186/s12889-021-11648-1.

引用本文的文献

1
Global, regional and national burdens of mental disorders, substance use disorders and self-harm among adolescents and young adults, 1990-2021: a systematic analysis for the Global Burden of Diseases Study 2021.1990 - 2021年全球、区域和国家青少年及青年精神障碍、物质使用障碍和自我伤害负担:全球疾病负担研究2021的系统分析
Eur Arch Psychiatry Clin Neurosci. 2025 Sep 9. doi: 10.1007/s00406-025-02115-8.
2
Global burden of mental disorders in 204 countries and territories results from the Global Burden of Disease Study 2021.204个国家和地区的精神障碍全球负担源自《2021年全球疾病负担研究》。
World J Psychiatry. 2025 Aug 19;15(8):106887. doi: 10.5498/wjp.v15.i8.106887.
3

本文引用的文献

1
Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019.精神分裂症的发病率、患病率和全球负担——来自全球疾病负担(GBD)2019 的数据,包括批判性评估。
Mol Psychiatry. 2023 Dec;28(12):5319-5327. doi: 10.1038/s41380-023-02138-4. Epub 2023 Jul 27.
2
Prevalence of depression and anxiety in older people in low- and middle- income countries in Africa, Asia and South America: A systematic review and meta-analysis.中低收入国家老年人中抑郁和焦虑的流行情况:非洲、亚洲和南美洲的系统评价和荟萃分析。
J Affect Disord. 2023 Mar 15;325:656-674. doi: 10.1016/j.jad.2023.01.068. Epub 2023 Jan 18.
3
Assessing the global burden of interstitial lung disease and pulmonary sarcoidosis using multiple statistical models: analysis and future projections.
使用多种统计模型评估间质性肺疾病和肺结节病的全球负担:分析与未来预测
BMC Pulm Med. 2025 Jul 24;25(1):352. doi: 10.1186/s12890-025-03813-8.
4
The burden of mental, and substance use disorders in Saudi Arabia: results from the global burden of disease study 2019.沙特阿拉伯精神和物质使用障碍的负担:2019年全球疾病负担研究结果
BMC Psychiatry. 2025 Jul 1;25(1):618. doi: 10.1186/s12888-025-07041-6.
5
Association between physical activity and risk of anxiety: a dose-response meta-analysis of 11 international cohorts.身体活动与焦虑风险之间的关联:对11个国际队列的剂量反应荟萃分析。
EClinicalMedicine. 2025 Jun 7;84:103285. doi: 10.1016/j.eclinm.2025.103285. eCollection 2025 Jun.
6
Efficacy and Safety of Once-Monthly Paliperidone Palmitate Long-Acting Injections in Chinese Patients with Early-, Mid-, and Late-Phase Schizophrenia: A Post-Hoc Analysis of Three Phase 4 Studies.每月一次棕榈酸帕利哌酮长效注射剂治疗中国早、中、晚期精神分裂症患者的疗效和安全性:三项4期研究的事后分析
CNS Drugs. 2025 Jun 15. doi: 10.1007/s40263-025-01194-4.
7
Global, regional, and national burden of mental disorders among women of reproductive age, 1990-2021: a systematic analysis of the global burden of disease study 2021.1990 - 2021年育龄妇女精神障碍的全球、区域和国家负担:全球疾病负担研究2021的系统分析
BMC Public Health. 2025 May 26;25(1):1943. doi: 10.1186/s12889-025-23134-z.
8
Assessment of awareness, practices, perceptions, and satisfaction of telepsychiatry among mental healthcare providers in Saudi Arabia.沙特阿拉伯精神卫生保健提供者对远程精神病学的认知、实践、看法及满意度评估。
Front Psychiatry. 2025 May 2;16:1426998. doi: 10.3389/fpsyt.2025.1426998. eCollection 2025.
9
Probiotics as technological innovations in psychiatric disorders: patents and research reviews.益生菌作为精神疾病的技术创新:专利与研究综述
Front Nutr. 2025 Apr 24;12:1567097. doi: 10.3389/fnut.2025.1567097. eCollection 2025.
10
Nursing strategies for implementing psychosocial interventions to address violence behavior in schizophrenia: a scoping review.实施心理社会干预以解决精神分裂症暴力行为的护理策略:一项范围综述
BMC Nurs. 2025 May 8;24(1):503. doi: 10.1186/s12912-025-03145-2.
Incidence, prevalence, and global burden of autism spectrum disorder from 1990 to 2019 across 204 countries.
1990年至2019年期间204个国家自闭症谱系障碍的发病率、患病率及全球负担。
Mol Psychiatry. 2022 Oct;27(10):4172-4180. doi: 10.1038/s41380-022-01630-7. Epub 2022 Jun 29.
4
Temporal trends in associations between severe mental illness and risk of cardiovascular disease: A systematic review and meta-analysis.严重精神疾病与心血管疾病风险之间关联的时间趋势:系统评价和荟萃分析。
PLoS Med. 2022 Apr 19;19(4):e1003960. doi: 10.1371/journal.pmed.1003960. eCollection 2022 Apr.
5
Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家 204 个地区 1990-2019 年 12 种精神障碍疾病的负担:基于 2019 年全球疾病负担研究的系统分析。
Lancet Psychiatry. 2022 Feb;9(2):137-150. doi: 10.1016/S2215-0366(21)00395-3. Epub 2022 Jan 10.
6
Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls.精神分裂症患者呼吸系统疾病发病率增高:一项包含 619214 例精神分裂症患者和 52159551 例对照者的系统评价和荟萃分析。
Schizophr Res. 2021 Nov;237:131-140. doi: 10.1016/j.schres.2021.08.022. Epub 2021 Sep 11.
7
Mental disorders among pregnant women during the COVID-19 pandemic. A cross-sectional study.COVID-19 大流行期间孕妇的精神障碍。一项横断面研究。
Sao Paulo Med J. 2022 Jan-Feb;140(1):87-93. doi: 10.1590/1516-3180.2021.0356.27052021.
8
Reducing the stigma of mental health disorders with a focus on low- and middle-income countries.关注中低收入国家,减少精神健康障碍污名化。
Asian J Psychiatr. 2021 Apr;58:102601. doi: 10.1016/j.ajp.2021.102601. Epub 2021 Feb 13.
9
Common mental disorders and perinatal depressive symptoms: an integrative review.常见精神障碍与围产期抑郁症状:综合述评。
Rev Bras Enferm. 2020 Oct 19;73Suppl 1(Suppl 1):e20190823. doi: 10.1590/0034-7167-2019-0823. eCollection 2020.
10
Promotion, prevention and treatment interventions for mental health in low- and middle-income countries through a task-shifting approach.通过任务转移方法在中低收入国家促进、预防和治疗精神卫生干预措施。
Epidemiol Psychiatr Sci. 2020 Aug 3;29:e150. doi: 10.1017/S204579602000061X.